Real-Time PCR (RT PCR), or quantitative PCR (QPCR), is a DNA sequence detection and quantitation method extensively used for DNA copy number detection, gene expression, SNP genotyping, adventitious agent detection, and many other applications in the fields of genomics research, drug R&D, and biologics testings.
Equipped with the state-of-art ABI 7900 HT Sequence Detection System, Avance Biosciences offers both Real-Time PCR or End-Point PCR assays
|Absolute Quantitation Assay||Real-time PCR assay with absolute quantitation determined via a Standard Curve.|
|Relative Quantitation Assay||This real-time PCR assay determines the fold-changes of the expression level of a gene relative to a calibrator or normalizing sample.|
|Allelic Discrimination Assay||End-point PCR assay used to determine the genotype (homozygotes or heterozygotes) of samples.|
|Plus/Minus Assay||End-point PCR assay used to determine the presence or absence of a specific target sequence in a sample.|
Our industry-leading quality system is designed and maintained to support drug and device research and development, GLP pre-clinical trials, cGMP biomanufacturing, and clinical trials.
Avance Biosciences provides biological testing services to support regulatory submission for clients around the world. These services are conducted under the requirements of Good Laboratory Practices and Current Good Manufacturing Practices as promulgated by the U.S. Food and Drug Administration 21 CFR Part 58 and 21 CFR Part 210 and 211, as well as Good Manufacturing Practice according to ICH Q7, where applicable to the laboratory services provided.